» Articles » PMID: 15337795

Use of Surgery Among Elderly Patients with Stage IV Colorectal Cancer

Overview
Journal J Clin Oncol
Specialty Oncology
Date 2004 Sep 1
PMID 15337795
Citations 83
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The role of surgery to remove the primary tumor among patients with stage IV colorectal cancer (CRC) is controversial. The purpose of this study was to evaluate surgical practice patterns for patients > or = 65 years of age with stage IV CRC in a US population-based cohort.

Patients And Methods: We used the Surveillance, Epidemiology, and End Results-Medicare-linked database to evaluate the patterns of cancer treatment for 9,011 Medicare beneficiaries presenting with stage IV CRC from 1991 to 1999. Patients were categorized according to whether they had primary-cancer-directed surgery (CDS) or no CDS within 4 months of diagnosis. The use of other treatment modalities, including metastasectomy, chemotherapy, and radiation, was evaluated in relationship to whether patients belonged to the CDS or no CDS group.

Results: Seventy-two percent (6,469 of 9,011) of patients received CDS, and their 30-day postoperative mortality was 10%. Patients with left-sided or rectal lesions, patients older than age 75 years, blacks, and those of lower socioeconomic status were less likely to undergo CDS; but even among those older than age 75, the CDS rate was 69% (3,378 of 4,909). In contrast, chemotherapy use was less common (47% for patients who had CDS and 31% for those who did not). Metastasectomy was rare; only 3.9% of patients underwent these operations at any point from diagnosis to death.

Conclusion: Palliative resection of the primary tumor is often performed for elderly US patients with stage IV colorectal cancer. This practice pattern merits re-evaluation, given the improvement in the efficacy of systemic chemotherapy.

Citing Articles

Primary tumor resection in colorectal cancer patients with unresectable distant metastases: a minireview.

Bai J, Yang M, Liu Z, Efetov S, Kayaalp C, Dulskas A Front Oncol. 2023; 13:1138407.

PMID: 37182188 PMC: 10172590. DOI: 10.3389/fonc.2023.1138407.


Development and validation of a clinical survival model for young-onset colorectal cancer with synchronous liver-only metastases: a SEER population-based study and external validation.

Li T, Liang Y, Wang D, Zhou Z, Shi H, Li M Front Oncol. 2023; 13:1161742.

PMID: 37143954 PMC: 10153626. DOI: 10.3389/fonc.2023.1161742.


Survival nomograms for colorectal carcinoma patients with lung metastasis and lung-only metastasis, based on the SEER database and a single-center external validation cohort.

Liu L, Sun J, Xiang Z BMC Gastroenterol. 2022; 22(1):446.

PMID: 36335295 PMC: 9636633. DOI: 10.1186/s12876-022-02547-9.


Survival outcomes in unresectable metastatic rectal cancer patients after both primary site resection and chemoradiotherapy: a SEER-based observational study.

Chen J, Chen H, Zhao F, Wang Z, Liu Q Transl Cancer Res. 2022; 11(1):171-180.

PMID: 35261894 PMC: 8841683. DOI: 10.21037/tcr-21-1399.


Metallic Nanoparticles for the Modulation of Tumor Microenvironment; A New Horizon.

Shariatzadeh S, Moghimi N, Khalafi F, Shafiee S, Mehrabi M, Ilkhani S Front Bioeng Biotechnol. 2022; 10:847433.

PMID: 35252155 PMC: 8888840. DOI: 10.3389/fbioe.2022.847433.